SCHEDULE: FMR LLC Discloses 15% Stake in Phibro Animal Health
Ownership Filing (Schedule 13G Amendment)
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 15.0% of Phibro Animal Health Corp's Class A Common Stock as of June 30, 2026.
Summary
- FMR LLC and Abigail P. Johnson, through various affiliated entities, have filed a Schedule 13G, reporting beneficial ownership of 3,160,280.92 shares of Phibro Animal Health Corp's Class A Common Stock.
- This holding represents 15.0% of the class of securities outstanding as of June 30, 2026.
- The filing indicates that FMR LLC has sole voting power and sole dispositive power over these shares.
- Abigail P. Johnson, as CEO of FMR LLC, is also listed, with her interest stemming from her role and ownership in FMR LLC.
- The filing is an amendment (Amendment No. 1) and confirms the reporting persons are not acting as a group for the purpose of influencing control.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant but stable institutional holding without immediate catalysts for major price movement.
Positives
- Significant institutional ownership by a major financial entity (FMR LLC) can lend stability and credibility to the company.
- The filing confirms a substantial, consistent holding, suggesting confidence from the reporting persons in Phibro Animal Health Corp's long-term prospects.
- The reporting persons hold sole voting and dispositive power, indicating clear control over their investment decisions.
Negatives
- The filing does not contain any negative financial performance indicators or operational concerns.
- No indication of any immediate plans to increase or decrease the stake significantly, suggesting a passive investment approach.
Risks
- While not explicitly stated as a risk in this filing, significant institutional holdings can sometimes lead to increased scrutiny or pressure on management for performance.
- The filing does not detail specific risks related to Phibro Animal Health Corp's business operations, as this is a Schedule 13G focused on ownership.
Future Outlook
This filing is primarily an ownership disclosure and does not contain forward-looking statements or specific business outlooks for Phibro Animal Health Corp.
Management Comments
- FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that significant institutional holdings, like the one reported by FMR LLC, are common in the animal health sector, reflecting investor confidence in the industry's growth potential driven by factors such as increasing global demand for animal protein and advancements in veterinary medicine.
Comparison to Industry Standards
- The 15.0% stake held by FMR LLC is a substantial position for an institutional investor in the animal health sector. Many publicly traded animal health companies have significant institutional ownership, often with top holders ranging from 5% to 20% or more.
- For comparison, major players in the animal health industry like Zoetis (ZTS) and Elanco Animal Health (ELAN) also show significant institutional ownership percentages, though specific holdings vary.
- This level of ownership by FMR LLC suggests a strong conviction, aligning with typical investment strategies of large asset managers who often take significant stakes in companies they believe have strong fundamentals and growth prospects.
Stakeholder Impact
- Shareholders: The significant stake held by FMR LLC may be viewed positively, indicating confidence from a major investor, potentially supporting share price stability.
- Management: The substantial holding by FMR LLC could imply a degree of oversight or influence on strategic decisions, though the filing states no intent to influence control.
- Creditors: No direct impact on creditors is indicated by this ownership filing.
Next Steps
- FMR LLC and Abigail P. Johnson will continue to hold their shares in Phibro Animal Health Corp.
- Future filings will be made if there are material changes in beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of prior Schedule 13G filing by FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of prior Schedule 13G filing by FMR LLC. |
| 2026-06-30 | Date of Event Which Requires Filing of this Statement (Reporting period end date). |
| 2026-08-05 | Date of joint filing agreement and signature date for the Schedule 13G. |
Keywords
Phibro Animal Health Corp, FMR LLC, Abigail P. Johnson, Schedule 13G, Institutional Ownership, Class A Common Stock, Beneficial Ownership, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.